Literature DB >> 17062276

Autocrine growth by granulocyte colony-stimulating factor in malignant mesothelioma.

Motohiro Nishimura1, Kyoko Itoh, Kazuhiro Ito, Masashi Yanada, Kunihiko Terauchi, Shinji Fushiki, Junichi Shimada.   

Abstract

We report the first case of a malignant mesothelioma expressing not only granulocyte-colony stimulating factor (G-CSF), but also its receptor. A 59-year-old male carpenter underwent a panpleuropneumonectomy, but the tumor relapsed and spread rapidly, accompanied by leukocytosis. The white blood cell count reached 147,000/mm3 (96.2% neutrophils), and the concentration of serum G-CSF was 77 pg/mL. An autopsy demonstrated that some of the tumor cells produced G-CSF, but more tumor cells and endothelial cells in the tumor expressed G-CSF receptor. It was hypothesized that an autocrine loop involving G-CSF and the G-CSF receptor greatly accelerated the tumor growth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17062276     DOI: 10.1016/j.athoracsur.2006.02.009

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Utilization of gene profiling and proteomics to determine mineral pathogenicity in a human mesothelial cell line (LP9/TERT-1).

Authors:  Jedd M Hillegass; Arti Shukla; Maximilian B MacPherson; Jeffrey P Bond; Chad Steele; Brooke T Mossman
Journal:  J Toxicol Environ Health A       Date:  2010

2.  A G-CSF-secreting adrenal carcinoma with rhabdoid-like differentiation causing leukocytosis.

Authors:  Emil Lou; Jeremy Goodwin; David N Howell; John Hicks; L Brett Caram
Journal:  Nat Rev Urol       Date:  2009-07       Impact factor: 14.432

3.  Granulocyte-colony stimulating factor (G-CSF) producing malignant pleural mesothelioma: Report of a case.

Authors:  Ayako Fujiwara; Masahiko Higashiyama; Takashi Kanou; Jiro Okami; Toshiteru Tokunaga; Yasuhiko Tomita; Ken Kodama
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

Review 4.  Chronic neutrophilic leukemia: new science and new diagnostic criteria.

Authors:  Natasha Szuber; Ayalew Tefferi
Journal:  Blood Cancer J       Date:  2018-02-13       Impact factor: 11.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.